Savior Lifetec Corporation (TPEX: 4167)
Health Care · Pharmaceuticals · TW
NT$22.00
+12.53% today · +34.3% 1Y
Savior Lifetec Corporation (TPEX: 4167) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $228.12M and employs 375 people.
Over the last twelve months the share price has gained 34.3%, trading between 15.40 and 22.40.
Tweenvest scores Savior Lifetec Corporation across four factors: quality 73/100, value 48/100, growth 54/100, dividend 64/100. Its strongest factor is quality.
4167 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $228.12M
- Revenue (TTM)
- $35.26M
- P/E
- 7.10
- EPS
- 3.10
- Dividend yield
- 3.42%
- Beta (5Y)
- 0.11
- 52-week high
- NT$22.40
- 52-week low
- NT$15.40
- Avg volume (3M)
- —
- Shares outstanding
- 331.55M
- Employees
- 375
- Next earnings
- —
About Savior Lifetec Corporation
Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various carbapenem generic drugs and injections, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. The company was founded in 1993 and is headquartered in Tainan City, Taiwan.
- ISIN
- TW0004167002
- Founded
- 1993
- Listed since
- Dec 21, 2012
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Daito Pharmaceutical Co.,Ltd.TSE: 4577 | $235.23M | ¥1,318.00 | +0.69% |
| Sol-Gel Technologies Ltd.NasdaqCM: SLGL | $234.97M | $72.70 | +1.30% |
| High Tide Inc.TSXV: HITI | $234.28M | CA$3.75 | +1.90% |
| Sakar Healthcare LimitedNSEI: SAKAR | $232.54M | Rs1,011.50 | -5.91% |
| Syncom Formulations (India) LimitedBSE: 524470 | $225.92M | Rs23.26 | -2.96% |
| Sai Parenteral's LimitedNSEI: SAIPARENT | $225.46M | Rs493.90 | -5.68% |
| Venus Remedies LimitedBSE: 526953 | $225.23M | Rs1,630.75 | -8.61% |
| Imexpharm CorporationHOSE: IMP | $220.14M | ₫37,000.00 | +1.09% |
Figures last refreshed Oct 11, 2026.